Health
‘Minuscule’ clotting risk after AstraZeneca Covid jabs: India – Macau Business
An analysis of adverse health effects in people who received the AstraZeneca Covid-19 vaccine in India found that the number of blood clot cases
An analysis of adverse health effects in people who received the AstraZeneca Covid-19 vaccine in India found that the number of blood clot cases was “minuscule”, the health ministry said Monday.
Some countries have restricted or dropped AstraZeneca shots from national vaccine campaigns over very rare blood clots, though experts have said the benefits outweigh the risks.
The Oxford-AstraZeneca jab — one of three shots granted emergency approval in India — is the most widely used in the country and…
-
Noosa News16 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Business17 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News19 hours ago‘They’re not taking the concerns of women seriously’
-
Business20 hours agoDividends from ASX 200 bank shares ‘looking very stretched’: expert